Picture 1 of 2
Gallery
Picture 1 of 2
Have one to sell?
Racing to a Cure : A Cancer Victim Refuses Chemotherapy Finds Tomorrow's Cures
US $15.99
ApproximatelyRM 68.41
Condition:
“Packed in a RIGID mailer with cardboard backing and padding. (See Photos)! Pages: not written on, ”... Read moreabout condition
Good
A book that has been read but is in good condition. Very minimal damage to the cover including scuff marks, but no holes or tears. The dust jacket for hard covers may not be included. Binding has minimal wear. The majority of pages are undamaged with minimal creasing or tearing, minimal pencil underlining of text, no highlighting of text, no writing in margins. No missing pages.
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Shipping:
Free USPS Media MailTM.
Located in: Van Nuys, California, United States
Delivery:
Estimated between Wed, 6 Aug and Fri, 8 Aug to 94104
Returns:
30 days return. Buyer pays for return shipping. If you use an eBay shipping label, it will be deducted from your refund amount.
Coverage:
Read item description or contact seller for details. See all detailsSee all details on coverage
(Not eligible for eBay purchase protection programmes)
Seller assumes all responsibility for this listing.
eBay item number:267050715852
Item specifics
- Condition
- Good
- Seller Notes
- Personalized
- No
- ISBN
- 9780252073571
About this product
Product Identifiers
Publisher
University of Illinois Press
ISBN-10
0252073576
ISBN-13
9780252073571
eBay Product ID (ePID)
50420608
Product Key Features
Number of Pages
456 Pages
Language
English
Publication Name
Racing to a Cure : A Cancer Victim Refuses Chemotherapy and Finds Tomorrow's Cures in Today's Scientific Laboratories
Subject
Diseases / Cancer, Oncology, Medical, Evidence-Based Medicine
Publication Year
2006
Type
Textbook
Subject Area
Health & Fitness, Biography & Autobiography, Medical
Format
Perfect
Dimensions
Item Height
1.1 in
Item Weight
22.1 Oz
Item Length
9 in
Item Width
6 in
Additional Product Features
Intended Audience
Trade
LCCN
2005-031432
Dewey Edition
22
Reviews
Racing to a Cure is a true adventure story complete with suspense, action, and the mysteries of cancer explained. The present relationship between all-knowing doctors and sheeplike patients should change into a partnership due to this book. It is must reading for anyone hoping to be cured of cancer., "In September 1998 publisher and scientific journalist Ruzic was diagnosed with mantle-cell lymphoma. . . . He faced a prognosticated further life-span of 18 months, and that would be made insufferable by side effects from the prescribed chemotherapy. . . . His scientific mind was certain that there were other, perhaps more effective and certainly less deadly treatment options, if one could find them. He made finding a cure for his cancer a full-time job. . . . He discovered that an abundance of biological therapies is being developed in the scientific, rather than the strictly medical arena, and he reports that those biotherapies and vaccines are proving highly effective for cancer treatment. His well-written memoir recounts a four-year odyssey that took him from splenectomy and diagnosis, through successfully ditching chemotherapy in favor of biotherapy, and to what he boldly calls a cure."-- Booklist (starred review), "[Ruzic] here chronicles his pursuit of a nontoxic cure for his mantle-cell lymphoma. No ordinary patient memoir, this book provides an intriguing glimpse into the world of cutting-edge cancer research from the perspective of a well-heeled, highly educated patient willing to challenge conventional medical wisdom. Instead of undergoing chemotherapy and a bone-marrow transplant, recommended by several oncologists despite poor survival rates, Ruzic visits cancer research laboratories around the country, attempting to enter clinical trials for new biotherapies such as monoclonal antibodies and vaccines. Though eventually successful, he is hampered at every turn by aspects of what he terms the 'Chemo Culture,' oncologists who insist on toxic chemotherapy while ignoring newer, safer options and FDA regulations that require chemotherapy before a patient can enroll in clinical trials of new therapies. . . . His arguments are thought-provoking and deserve a wide audience. Recommended for academic, medical, public, and consumer health collections."-- Library Journal
Dewey Decimal
362.196/9940092 B
Table Of Content
Cover Title Copyright Contents Preface 1. Into the Pit 2. Watch and Learn 3. The Chemo Culture 4. Life before Cancer 5. Our War Within 6. A Half-Billion for Proof 7. The Language of Medicine 8. Cancer Vaccines 9. Premature Results 10. Co-stimulating T Cells 11. Do They Have to Die? 12. Alternative Magic 13. Allies in the Quest 14. False Alarm 15. Does Prayer Work? 16. Project Indolence 17. Cure Cancer in Ten Years 18. Think Tanks 19. Transplants: Risk vs. Cure 20. Pathways to Success 21. From India with Results 22. Anti-angiogenesis 23. The Mystery of Splenectomy 24. The Strep Connection 25. Patient Rage 26. The Biotherapy Revolution 27. Detour 28. Cure! 29. Waiting for Bexxar DAVID RUZIC 30. The End of the Race DAVID RUZIC Acknowledgments Notes Glossary Index Back cover
Synopsis
Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories. Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients. Ruzic, a former scientific magazine publisher and originator of a science center, refused to accept this status quo, and instead plunged into the world of cutting-edge treatments, exploring the frontiers of cancer science with revolutionary results. Ruzic went on the offensive: visiting scores of laboratories, gathering information, talking to researchers, and effectively becoming his own patient-care advocate. This book presents his findings. A scathing critique of the chemotherapy culture as well as unscientific "alternative" therapies, the book endorses state-of-the-art molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians. Neil Ruzic was expected to die within two years of his initial diagnosis. Five years later he has been declared cancer-free and considers himself cured., Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by ......, When Neil Ruzic was diagnosed with mantle-cell lymphoma, he declined the recommended chemotherapy & went on a quest for a more effective cure, visiting cancer research laboratories & investigating the latest molecular therapies. This memoir records his successful search for a cure., In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system. Unhappy with the success rates of standard chemotherapy and radiation treatments, Ruzic took control of his destiny and began to investigate the cutting-edge cures being developed in research laboratories. Going on the offensive, Ruzic visited scores of laboratories, talked to researchers, gathered information, and effectively became his own patient-care advocate. Racing to a Cure provides a scathing critique of the chemotherapy culture as well as of unscientific "alternative" therapies and endorses state-of-the-art, molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians. Although expected to die within two years of his initial diagnosis, Neil Ruzic survived for more than five years before the cancer returned and claimed his life in January 2004. David Ruzic has added new material to this edition to explain the most recent cancer therapies for mantle-cell lymphoma as well as celebrate his father's achievements in extending his life, exploding myths about cancer, and setting precedents for patients wanting more from their treatment., Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories. Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients. Ruzic, a former scientific magazine publisher and originator of a science center, refused to accept this status quo, and instead plunged into the world of cutting-edge treatments, exploring the frontiers of cancer science with revolutionary results. Ruzic went on the offensive: visiting scores of laboratories, gathering information, talking to researchers, and effectively becoming his own patient-care advocate. This book presents his findings. A scathing critique of the chemotherapy culture as well as unscientific ''alternative'' therapies, the book endorses state-of-the-art molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians.Neil Ruzic was expected to die within two years of his initial diagnosis. Five years later he has been declared cancer-free and considers himself cured.
LC Classification Number
RC280
Item description from the seller
Seller feedback (2,394)
- 7***d (35)- Feedback left by buyer.Past monthVerified purchaseThank you. Excellent.
- 7***d (35)- Feedback left by buyer.Past monthVerified purchaseThank you. Excellent.
- 7***d (35)- Feedback left by buyer.Past monthVerified purchaseThank you. Excellent.
More to explore :
- Fiction Books & Fiction Tomorrow Series,
- Tomorrow Series Fiction Paperbacks Books,
- Tomorrow Series Fiction Hardcovers Books,
- Fiction Books & Tomorrow Series Fiction Illustrated,
- Tomorrow Series Fiction & Signed Fiction Books,
- Tomorrow Series Fiction & Books with Vintage Fiction,
- Tomorrow Series Fiction & Books with Dust Jacket Fiction,
- Tomorrow Series Fiction Fiction Books & 1950-1999 Publication Year,
- Tomorrow Series Fiction Fiction Books with Dust Jacket & 1950-1999 Publication Year,
- Debbie Macomber Tomorrow Series Fiction 2010-Now Publication Year Fiction & Books
Seller feedback (2,394)
- 7***d (35)- Feedback left by buyer.Past monthVerified purchaseThank you. Excellent.
- 7***d (35)- Feedback left by buyer.Past monthVerified purchaseThank you. Excellent.
- 7***d (35)- Feedback left by buyer.Past monthVerified purchaseThank you. Excellent.